Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04054349 · ClinicalTrials.gov registry record · NA

The Effect of the Low Fodmap Diet in Children With Autism Spectrum Disorders

A NA study of Autism Spectrum Disorder, sponsored by Ohio State University.

Completed
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT04054349 is a NA study of Autism Spectrum Disorder that has completed, run by Ohio State University. The registered enrollment target is 15 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04054349, a NA study of Autism Spectrum Disorder, has completed, sponsored by Ohio State University.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

This study assesses the effect of the low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) diet on gastrointestinal (GI) and behavioral problems in children with autism spectrum disorder (ASD). The objectives of this study are: -To determine whether the low FODMAP diet causes a decrease in gastrointestinal problems related to ASD -To determine whether the low FODMAP diet causes a decrease in behavioral problems -To assess the effect of decreased gastrointestinal problems on reduction of behavioral problems

Conditions Studied

Interventions

  • OTHER Low FODMAP diet

Study Locations (1)

Ohio

  • The Ohio State University Nisonger Center - Columbus

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2019-01-03
Est. Completion 2019-07-30
Phase NA

Sponsor

Ohio State University

552 total trials

What the Registry Record Tells You About NCT04054349

The ClinicalTrials.gov registry entry for NCT04054349 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (89% lower). The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 1 intervention - of which Low FODMAP diet is the first listed.

NCT04054349 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT04054349 about?

NCT04054349 is a clinical study titled "The Effect of the Low Fodmap Diet in Children With Autism Spectrum Disorders". This study assesses the effect of the low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) diet on gastrointestinal (GI) and behavioral problems in children with autism spectrum disorder (ASD). The objectives of this study are: -To determine whether the low FODMAP d...

What is the current status of trial NCT04054349?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2019-01-03. Estimated completion is 2019-07-30.

What conditions does trial NCT04054349 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder.

What interventions are being tested in trial NCT04054349?

The interventions under investigation include: Low FODMAP diet (OTHER).

Who is sponsoring clinical trial NCT04054349?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04054349 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.